Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, announced its participation in two upcoming November events. The company will be a silver sponsor of Wonderland Miami, the largest in-person conference focused on the psychedelic medicine industry. At Wonderland, MINDCURE president and CEO Kelsey Ramsden will participate in several panel discussions scheduled during the in-person, two-day event. Slated for Nov. 8–9, 2021, Wonderland Miami is presented by Microdose Psychedelic Insights, a portfolio company of Origin Therapeutics. In addition, MINDCURE is also scheduled to participate in next month’s International Summit on Psychedelic Therapies for Mental Illness. The two-day summit, scheduled for Nov. 19–20, will be a virtual event based in Australia. During that event, Ramsden will be a member of a panel that is scheduled to discuss the future of the psychedelic industry and what it will look like in five years. The summit is presented by Mind Medicine Australia (“MMA”), and MINDCURE is a supporting partner of that organization.

To attend the events, visit https://ibn.fm/GDdQD and https://ibn.fm/48jmL

To view the full press release, visit https://ibn.fm/kFPXE

About Mind Cure Health Inc.

MINDCURE is a life sciences company focused on innovating and commercializing new ways to promote healing and improve mental health. The company is developing digital therapeutics technology and researching psychedelic compounds to support access to safe, evidence-based, psychedelic-assisted therapies globally. For more information about the company, please visit www.MindCure.com.

NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.